Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters











Publication year range
1.
Ciênc. Saúde Colet. (Impr.) ; Ciênc. Saúde Colet. (Impr.);20(1): 125-136, jan. 2015.
Article in Portuguese | LILACS | ID: lil-733138

ABSTRACT

O conceito de recovery tem sido descrito em artigos como um estado de recuperação ou restabelecimento de funções psíquicas, físicas e sociais no funcionamento cotidiano. O objetivo do artigo é analisar concepções terminológicas em diferentes metodologias investigativas e a evolução paradigmática da noção de recovery. Pesquisa bibliográfica sistemática na base Pubmed com as palavras "recovery + schizophrenia", limitada a dois anos retrospectivos e a artigos completos gratuitos. Dezenove artigos foram analisados. A maioria destes busca associações entre dada característica e recovery, poucos são aqueles que discutem a sua concepção de forma que se distinga de termos comuns como "cura" e "reabilitação". Recovery como um estado em que o portador de transtorno mental grave possa sentir-se criador de seus caminhos tende a estar presente em estudos com metodologia qualitativa e em revisões bibliográficas, em que a medida de recovery deixa de relacionar-se à ausência de sintomas e passa a priorizar o quão participativa pode ser a vida de um indivíduo apesar da doença. Alguns estudos quantitativos vislumbram essa diferença conceitual. Em pesquisas qualitativas ocorre expansão na concepção de recovery e nas formas de promovê-lo.


The concept of recovery has been described in papers as a state of psychic, physical and social recuperation of day-to-day functions. The scope of this article is to analyze the concepts of the term in different research methodologies and the paradigmatic evolution of the recovery concept. Systematic bibliographical research was conducted in the Pubmed database using the words "recovery + schizophrenia" limited to freely available full papers published in the previous two years. Nineteen papers were analyzed. The majority of the papers sought associations between characteristic data and recovery; few papers discussed the concept in a way to distinguish it from other words like cure or rehabilitation. Recovery as a state in which people with severe mental illness can feel like the creators of their own itinerary tend to be found in qualitative studies and in bibliographic reviews in which the meaning of recovery is not related to the lack of symptoms and tends to prioritize how participative the life of an individual can be despite the disease. Some quantitative studies detect this conceptual difference. In qualitative research there is an increase in the concept of recovery and in ways of promoting it.


Subject(s)
Animals , Arsenicals/pharmacology , Heteroptera/drug effects , Leucine/analogs & derivatives , Toxicity Tests/methods , Heteroptera/growth & development , Heteroptera/physiology , Leucine/toxicity , Plants, Genetically Modified , Pollen/chemistry , Time Factors
2.
Rev. bras. ginecol. obstet ; Rev. bras. ginecol. obstet;37(1): 42-51, 01/2015. tab
Article in English | LILACS | ID: lil-732870

ABSTRACT

Gestational trophoblastic neoplasia (GTN) is the term to describe a set of malignant placental diseases, including invasive mole, choriocarcinoma, placental site trophoblastic tumor and epithelioid trophoblastic tumor. Both invasive mole and choriocarcinoma respond well to chemotherapy, and cure rates are greater than 90%. Since the advent of chemotherapy, low-risk GTN has been treated with a single agent, usually methotrexate or actinomycin D. Cases of high-risk GTN, however, should be treated with multiagent chemotherapy, and the regimen usually selected is EMA-CO, which combines etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine. This study reviews the literature about GTN to discuss current knowledge about its diagnosis and treatment.


Neoplasia trofoblástica gestacional (NTG) é o termo que descreve o conjunto de anomalias malignas da placenta, incluindo a mola invasora, coriocarcinoma, tumor trofoblástico do sítio placentário e tumor trofoblástico epitelióide. Ambos a mola invasora e o coriocarcinoma respondem bem à quimioterapia, com taxas de cura superiores a 90%. Desde o advento da quimioterapia, NTG de baixo risco tem sido tratada com monoquimioterapia, pelo geral methotrexate ou actinomicina-D. Casos de NTG de alto risco, contudo, devem ser tratados com poliquimioterapia, e o regime usualmente escolhido é o EMA-CO que combina etoposide, methotrexate, actinomicina-D, ciclofosfamida e vincristina. Esse estudo revê a literatura sobre NTG a fim de discutir os conhecimentos atuais sobre seu diagnóstico e tratamento.


Subject(s)
Animals , Male , Rats , Cathepsins/analysis , Cystatins/analysis , Cysteine Proteinase Inhibitors/metabolism , Endopeptidases , Leucine/analogs & derivatives , Osteoclasts/chemistry , Osteoclasts/enzymology , Salivary Proteins and Peptides/analysis , Bone Matrix/chemistry , Bone Matrix/enzymology , Cathepsin L , Cysteine Endopeptidases , Cathepsins/antagonists & inhibitors , Cathepsins/metabolism , Cystatins/metabolism , Cysteine Proteinase Inhibitors/toxicity , Leucine/metabolism , Leucine/toxicity , Lysosomes/enzymology , Microscopy, Immunoelectron , Osteoclasts/drug effects , Osteoclasts/ultrastructure , Rats, Wistar , Salivary Cystatins
3.
Aquat Toxicol ; 110-111: 99-106, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22281778

ABSTRACT

Gallbladder bile from 2 fish species, mullet (Mugil liza) and tilapias (Tilapia rendalli), contain substantial matrix metalloproteinases (MMPs). Extensive purification studies were conducted in order to obtain workable samples for SDS-PAGE and zymography analysis. Proteinase activities were assayed by gelatin substrate zymography. Several protein bands were observed, corresponding to molecular weights of 200, 136, 43, 36, 34, 29, 23 and 14 kDa in mullet bile and 179, 97, 79, 61, 54, 45, 36, 33 and 21 kDa in tilapia bile. Specific inhibitor studies were conducted, in which MMPS were inhibited by EDTA and 1,10 phenanthroline, but not by serine and cysteine protease inhibitors, such as phenylmethylsulfonyl fluoride (PMSF) and transepoxysuccinyl-l-leucylamido-l-guanidino butane (E-64), confirming the proteinase identities as MMPs. Differences in proteinase expression were observed in fish from a contaminated and reference site. Some studies regarding MMPs in different fish tissues exist, however this is the first study conducted in fish bile, and their involvement in detoxification processes and organism protection against the effects of aquatic contaminants may be a possibility.


Subject(s)
Bile/metabolism , Environmental Monitoring/methods , Matrix Metalloproteinases/metabolism , Water Pollutants, Chemical/toxicity , Animals , Biomarkers/metabolism , Electrophoresis, Polyacrylamide Gel , Fishes , Leucine/analogs & derivatives , Leucine/toxicity , Phenylmethylsulfonyl Fluoride/toxicity
4.
Brain Res ; 1324: 75-84, 2010 Apr 09.
Article in English | MEDLINE | ID: mdl-20153737

ABSTRACT

Patients affected by maple syrup urine disease (MSUD) present severe neurological symptoms and brain abnormalities, whose pathophysiology is poorly known. In the present study we investigated the in vitro effects of leucine (Leu), alpha-ketoisocaproic acid (KIC) and alpha-hydroxyisovaleric acid (HIV), respectively, the branched-chain amino, keto and hydroxy acids that most accumulate in MSUD, on brain bioenergetic homeostasis, evaluating respiratory parameters obtained by oxygen consumption, membrane potential (Psim), NAD(P)H content, swelling and citric acid cycle enzyme activities in mitochondrial preparations from rat forebrain using glutamate plus malate, succinate or alpha-ketoglutarate as respiratory substrates. KIC increased state 4 and decreased the respiratory control ratio with all substrates, in contrast with Leu and HIV. Furthermore, KIC and Leu, but not HIV, decreased state 3 using alpha-ketoglutarate. A KIC-induced selective inhibition of alpha-ketoglutarate dehydrogenase activity was also verified, with no alteration of the other citric acid cycle activities. The ADP/O ratio and the mitochondrial NAD(P)H levels were also reduced by KIC using glutamate/malate and alpha-ketoglutarate. In addition, KIC caused a reduction in the Psim when alpha-ketoglutarate was the substrate. Finally, KIC was not able to induce mitochondrial swelling. The present data indicate that KIC acts as an uncoupler of oxidative phosphorylation and as a metabolic inhibitor possibly through its inhibitory effect on alpha-ketoglutarate dehydrogenase activity, while Leu acts as a metabolic inhibitor. It is suggested that impairment of mitochondrial homeostasis caused by the major metabolites accumulating in MSUD may be involved in the neuropathology of this disease.


Subject(s)
Brain/drug effects , Central Nervous System Agents/toxicity , Keto Acids/toxicity , Leucine/toxicity , Mitochondrial Diseases/chemically induced , Animals , Brain/physiopathology , Electron Transport/drug effects , Homeostasis/drug effects , Ketoglutarate Dehydrogenase Complex/metabolism , Maple Syrup Urine Disease , Membrane Potential, Mitochondrial/drug effects , Mitochondrial Diseases/physiopathology , Mitochondrial Swelling/drug effects , NADP/metabolism , Oxygen Consumption/drug effects , Prosencephalon/drug effects , Prosencephalon/physiopathology , Rats , Rats, Wistar , Valerates/toxicity
5.
J Dent Child (Chic) ; 76(2): 123-9, 2009.
Article in English | MEDLINE | ID: mdl-19619425

ABSTRACT

Chemomechanical caries removal allies an atraumatic technique with antimicrobiotic characteristics, minimizing painful stimuli and maximally preserving healthy dental structures. The purpose of this study was to compare the cytotoxic effects of papain-based gel (Papacarie) and another caries-removing substance, Carisolv, to a nontreatment control on cultured fibroblasts in vitro and the biocompatibility in subcutaneous tissue in vivo. The cytotoxicity analysis was performed on fibroblast cultures (NIH-3T3) after 0-, 4-, 8-, and 12-hour exposure (cell viability assay) and after 1-, 3-, 5-, and 7-day exposure (survival assay). In the in vivo study, the 2 compounds were introduced into polyethylene tubes that were implanted into subcutaneous tissues of rats. After 1, 7, 14, 30, and 60 days, tissue samples were examined histologically. Cell viability did not differ between the 2 experimental groups. The control group, however, showed significantly higher percentage viability. There were no differences in cell survival between the control and experimental groups. The histological analysis revealed a moderate inflammatory response at 2 and 7 days and a mild response at 15 days, becoming almost imperceptible by 30 and 60 days in both experimental groups. The 2 tested substances exhibited acceptable biocompatibilities and demonstrated similar responses in the in vitro cytotoxicity and in vivo implantation assay.


Subject(s)
Dental Caries/therapy , Dental Cavity Preparation/methods , Fibroblasts/drug effects , Glutamic Acid/toxicity , Leucine/toxicity , Lysine/toxicity , Papain/toxicity , Analysis of Variance , Animals , Biocompatible Materials/toxicity , Cell Survival/drug effects , Cells, Cultured , Dental Cavity Preparation/instrumentation , Dental Pulp/drug effects , Rats
6.
Gen Dent ; 52(6): 506-8, 2004.
Article in English | MEDLINE | ID: mdl-15636274

ABSTRACT

This study was designed to investigate in vivo subcutaneous tissue reactions after Carisolv contact in a mouse model. Eighteen mice were implanted with two polyethylene tubes: the implant on the right side included a sponge soaked in Carisolv; the implant on the left side served as a control. Similar tissue response was displayed in both test and control groups, suggesting that Carisolv does not result in adverse effects as compared with a control. The tendency of connective tissue encapsulating the implants in both groups may result from the presence of materials that can be well-tolerated by the organism.


Subject(s)
Dental Materials/toxicity , Glutamic Acid/toxicity , Leucine/toxicity , Lysine/toxicity , Subcutaneous Tissue/drug effects , Animals , Dental Cavity Preparation/adverse effects , Female , Mice , Mice, Inbred BALB C
7.
Braz J Med Biol Res ; 20(6): 665-74, 1987.
Article in English | MEDLINE | ID: mdl-3331952

ABSTRACT

Amino acid esters can disrupt lysosomes and damage monocytes and certain lymphocyte populations. Lysosomal disruption involves pH trapping of the esters, followed by their hydrolysis by as yet unidentified enzymes. Accumulation of the more polar amino acids is assumed to cause osmotic lysis of the organelles. We have discovered that certain amino acid esters and amides destroy Leishmania mexicana amazonensis amastigotes lodged within macrophages in culture, as well as parasites isolated from mouse lesions. This paper reviews the amino acid specificity of parasite killing, the resistance of amastigotes derived from infection of macrophages with promastigotes, the involvement of an acidified compartment within the parasites, and the protection conferred by other amino acid esters, and by the protease inhibitors antipain and chymostatin, against the destruction of amastigotes by Leucine-methyl ester. Studies with tritiated esters confirm the critical role of ester hydrolysis for leishmanicidal activity and strengthen the view that similar mechanisms underlie disruption of lysosomes and destruction of Leishmania. Characterization of the parasite organelles and of the enzymes involved in the leishmanicidal activity as well as structure-activity studies may permit the design of compounds more selective for the parasites.


Subject(s)
Dipeptides/pharmacology , Leishmania mexicana/drug effects , Leucine/analogs & derivatives , Lysosomes/drug effects , Animals , Dipeptides/therapeutic use , Leishmania mexicana/enzymology , Leucine/pharmacology , Leucine/therapeutic use , Leucine/toxicity , Protease Inhibitors/pharmacology , Protease Inhibitors/therapeutic use
8.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;20(6): 665-74, 1987.
Article in English | LILACS | ID: lil-77412

ABSTRACT

Amino acid esters can disrupt lysosomes and damage monocytes and certain lymphocyte populations. Lysosomal disruption involves pH trapping of the esters, followed by their hydrolyssis by as yet unidentified enzymes. Accumulation of the more polar amino acids is assumed to cause osmotic lysis of the organelles. we have discovered that certain amino acid esters and amides destroy Leishmania mexicana amazonensis amastigores lodged within macrophages in culture, as well as parasites isolated from mouse lesions. This paper reviews the amino acid specificity of parasite killing, the resistance of amastigotes derived from infection of macrophages with promastigotes, the involvement of an acidified compartment within the parasites, and the protection conferred by other amino acid esters, and the protease inhibitors antipain and chymostatin, aginst the destruction of amastigotes by Leucine-methyl ester. Studies with tritiated esters confirm the critical role of ester hydrolysis for leishmanicidal activity and strengthen the view that similar mechanisms underlie disruption of lysosomes and destruction of Leismania. Characterization of the parasite organelles and of the enzymes involved in the leishmanicidal activity as well as structure-activity studies may permit the design of compounds mor selective for the parasites


Subject(s)
Animals , Dipeptides/pharmacology , Leishmania mexicana/drug effects , Leucine/analogs & derivatives , Lysosomes/drug effects , Dipeptides/therapeutic use , Leishmania mexicana/enzymology , Leucine/pharmacology , Leucine/therapeutic use , Leucine/toxicity , Protease Inhibitors/pharmacology , Protease Inhibitors/therapeutic use
10.
West Indian med. j ; 18(1): 34-9, Mar. 1969.
Article in English | MedCarib | ID: med-10753

ABSTRACT

The amino acid leucine, administered to pregnant rats during early gestation, induced a high incidence of multiple congenital abnormalities and foetal resorptions. These adverse effects may be accounted for by an imbalance in the amino acid pool, which is available for protein synthesis during embryonic development (AU)


Subject(s)
Pregnancy , 21003 , Female , Abnormalities, Drug-Induced , Fetus/drug effects , Leucine/toxicity , Amino Acids/toxicity , Fetal Diseases/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL